CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
about
Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidenceCirculating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewmiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsSmall-molecule inhibitors of the Myc oncoproteinCXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cellsTherapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAsMicroenvironmental regulation of therapeutic response in cancerMicroRNAs: novel players in cancer diagnosis and therapies.MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells.The intricate role of CXCR4 in cancer.Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatinPolymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells.miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expressionAntileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth.miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies.miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous LeukemiaMicroRNA-mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients.Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes.Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemiaMiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia.miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.The Role of miRNA in Haematological Malignancy.CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.Roadblocks to translational advances on metastasis research.Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.CXCR4 as biomarker for radioresistant cancer stem cells.CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.The Interplay between PP2A and microRNAs in Leukemia.Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment.Targeting the microenvironment in acute myeloid leukemia.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Central nervous system niche involvement in the leukemia.MicroRNAs in Myeloid Hematological Malignancies.
P2860
Q26770388-38C68C62-6ECB-4781-A69F-CDCA54CA404EQ26785539-C154A0A2-F5DB-40EB-8E73-185986351FFAQ27023295-9E27C6D3-05DB-4805-A2B6-F45A956AD7B6Q27025648-7C272E46-EC5F-4179-AD5C-31127A114181Q27324358-DE13E0EA-AA29-4C01-992F-9E75AA20FB24Q27329605-13534D5E-1E0D-47F4-A826-449169F2F7DAQ28071427-95E6924D-4ACC-4B8F-880B-AD7AC29565F7Q33654609-C43401E1-C634-4CC6-8CE9-AAAB2AE5D944Q33914573-F07D7756-9D01-4A92-98EF-C5FBEB34A5E6Q33917538-D09E868F-985E-40E8-BAB4-EDB9C5CA1F0CQ33917640-6DB7B379-E578-478D-9025-477961A9B57AQ35067624-0C8DA091-2D38-4968-88BF-70250A64BF6BQ35175999-6B20EDB0-D3D6-478C-A56E-E9CC1F216596Q35507696-D65F5E34-85EE-4F0B-AD3F-5BB2382E0C85Q35742473-A6B0F8DD-985C-410E-9E51-A6DFAD79CC64Q35836868-988422A9-F52F-4DD5-A76C-63C685FF56F6Q35990849-E9E5C754-A145-491A-A84D-3E0DB6F41373Q36247617-A9D86A0C-CC7A-4BCD-8975-01D981D73A35Q36256357-8C8C4328-85D9-41D7-983B-F7D515FA5F98Q36331291-1E3E62C4-90A3-465C-8415-EABAD212EC3BQ36511384-C23746D7-4A7C-4590-B921-6C7060CC0CCEQ36807754-9F9F369F-3242-4CF0-8789-91B529690C4FQ37094051-C4E76790-5849-43C9-9F9C-12C0E525AAA0Q37295285-67204692-EF05-45CF-9187-4259F22A098CQ37295313-046AB524-D136-4AEE-8A97-4699548119E9Q37362705-AC27B510-C08E-442B-A3B4-2865383F752CQ37376531-7DCC800C-5DCC-405D-9958-10B50DBF5F32Q37422388-D3EA672A-A90C-4397-9D8B-F273CFB53E41Q37630462-22D41389-7199-4DFA-B7E5-D0412868FE62Q37679393-0B0F96BF-9148-4997-BBB1-F8756FF050FBQ37683451-ECC03436-45F0-4A29-B732-E9EF333A1FBCQ37706651-A3717BFD-F287-49B2-8410-C77166EACB9BQ38197709-112579C4-D4C4-48AF-A051-632DD08CCFA9Q38209604-4EF38ECF-32A0-4907-BEBB-DCB1C61B3B4AQ38370368-BF7319CC-BF25-4C28-8944-465B8E1AF9F4Q38398064-076B8E1B-3BDC-4197-9FC2-7A25FA5A3199Q38447268-1D8158AC-73D2-46F3-9561-1E163CFEA2EDQ38546133-E452215D-B9F5-44CC-BBAD-83D512CBF00CQ38560970-04212958-A553-418B-954E-F873CDAD9B38Q38599595-C7DCD9A3-0283-426F-AA10-53C09B95C094
P2860
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
@en
type
label
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
@en
prefLabel
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
@en
P2093
P2860
P50
P356
P1476
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.
@en
P2093
Ramiro Garzon
Rodrigo Jacamo
P2860
P304
P356
10.1172/JCI66553
P407
P577
2013-05-08T00:00:00Z